These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3090558)

  • 1. Prevention of neural myoinositol depletion in diabetic rats by aldose reductase inhibition with tolrestat.
    Kemper C; Dvornik D
    Proc Soc Exp Biol Med; 1986 Sep; 182(4):505-10. PubMed ID: 3090558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors.
    Sredy J; Flam BR; Sawicki DR
    Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
    Tomlinson DR; Sidenius P; Larsen JR
    Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged fructose feeding and aldose reductase inhibition: effect on the polyol pathway in kidneys of normal rats.
    Bellomo G; Comstock JP; Wen D; Hazelwood RL
    Proc Soc Exp Biol Med; 1987 Dec; 186(3):348-54. PubMed ID: 3122222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat.
    McCaleb ML; Sredy J; Millen J; Ackerman DM; Dvornik D
    J Diabet Complications; 1988; 2(1):16-8. PubMed ID: 2968349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats.
    Yue DK; Hanwell MA; Satchell PM; Handelsman DJ; Turtle JR
    Metabolism; 1984 Dec; 33(12):1119-22. PubMed ID: 6438438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA; Cameron NE; Hohman TC
    J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
    Hirata Y; Fujimori S; Okada K
    Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration.
    Williamson JR; Chang K; Tilton RG; Prater C; Jeffrey JR; Weigel C; Sherman WR; Eades DM; Kilo C
    Diabetes; 1987 Jul; 36(7):813-21. PubMed ID: 3108058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats.
    Simard-Duquesne N; Greselin E; Dubuc J; Dvornik D
    Metabolism; 1985 Oct; 34(10):885-92. PubMed ID: 3930915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235.
    Yasuda H; Sonobe M; Yamashita M; Terada M; Hatanaka I; Huitian Z; Shigeta Y
    Diabetes; 1989 Jul; 38(7):832-8. PubMed ID: 2525492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolrestat, an aldose reductase inhibitor, prevents nerve dysfunction in conscious diabetic rats.
    Notvest RR; Inserra JJ
    Diabetes; 1987 Apr; 36(4):500-4. PubMed ID: 3102300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy.
    Sredy J; Sawicki DR; Notvest RR
    J Diabet Complications; 1991; 5(1):42-7. PubMed ID: 1830318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.
    Raccah D; Coste T; Cameron NE; Dufayet D; Vague P; Hohman TC
    J Diabetes Complications; 1998; 12(3):154-62. PubMed ID: 9618071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
    Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H
    Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol.
    Mayer JH; Tomlinson DR; McLean WG
    J Neurochem; 1984 Nov; 43(5):1265-70. PubMed ID: 6208327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH; Ross IS
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.
    Willars GB; Calcutt NA; Tomlinson DR
    Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.